Compliance & Patient Rights

Medical Disclaimer & Legal Information

Clear, binding declarations concerning clinical eligibility, investigational treatment protocols, outcome expectations, and data privacy safeguards.

MD

Clinical Oversight & Legal Verification

E-E-A-T Verified
Medical Advisory Board & Legal Compliance Committee

This policy conforms strictly to the National Guidelines for Stem Cell Research (ICMR-DBT), the Digital Personal Data Protection Act 2023 (DPDP), and international patient safety standards.

Last Audited: March 2026 View Editorial Policy →
Mandatory Clinical Advisory: Stem cell procedures offered for degenerative, neuromuscular, and chronic organ disorders are provided as investigational clinical treatments under Institutional Committee for Stem Cell Research (IC-SCR) and Institutional Ethics Committee (IEC) oversight. They do not constitute established curative prescriptions.

1. Medical Information & Educational Purpose

All content provided on this website—including medical articles, clinical explanations, video testimonials, procedure descriptions, and pricing guidelines—is published solely for informational and educational purposes. It is not intended to be a substitute for direct medical diagnosis, professional advice, or individualized physician consultation.

Never disregard professional medical guidance or delay seeking urgent clinical evaluation because of information you have read on this website. If you believe you may be experiencing a medical emergency, call your local emergency services or consult a hospital immediately.


2. Investigational Status & ICMR-DBT Framework

In accordance with the National Guidelines for Stem Cell Research formulated by the Indian Council of Medical Research (ICMR) and the Department of Biotechnology (DBT), Government of India:

  • Standard Approved Indications: Hematopoietic stem cell transplantation (HSCT) using bone marrow, peripheral blood, or umbilical cord blood is standard approved therapy for defined hematological malignancies and specific immunodeficiencies.
  • Investigational Indications: Cellular therapy applications for neurological conditions (e.g., ALS, Cerebral Palsy, Stroke Rehab), chronic kidney disorders, autoimmune diseases, and osteoarthritis are classified as experimental/investigational.
  • Institutional Oversight: All investigational protocols facilitated through our network are reviewed and monitored by accredited Institutional Ethics Committees (IEC) and Institutional Committees for Stem Cell Research (IC-SCR).

3. Biological Variability & No Outcome Guarantees

Stem cell biology operates through complex cellular and paracrine interactions within living human tissue. As a consequence:

  • No Universal Cure: Cellular therapies are not a 100% cure. Our clinical goal is cellular repair, reduction of inflammatory markers, symptom stabilization, and enhancement of overall quality of life.
  • Individual Variability: Every patient possesses unique immunological, genetic, and metabolic profiles. Even with identical diagnoses and cell dosages, clinical responses vary substantially between individuals.
  • No Guarantees: Stem Cell Therapy Center India, our associated physicians, and hospital partners explicitly make no guarantees, warranties, or predictions regarding specific percentage improvements or long-term clinical outcomes.

4. Strict Ethical Standards: Zero Embryonic Cell Usage

To uphold the highest medical ethics and international compliance:

We strictly DO NOT use embryonic or fetal stem cells. All protocols utilize ethically obtained autologous adult cells (patient's own bone marrow or adipose tissue) or screened allogeneic mesenchymal stem cells derived from donated umbilical cord Wharton’s jelly following healthy, full-term cesarean births with voluntary maternal consent.


5. Patient Pre-Screening & Clinical Safety Profile

Prior to administering any cellular therapy, our clinical team conducts a comprehensive diagnostic workup:

Pre-Admission Diagnostics
  • Complete blood counts and renal/liver panels
  • Infectious disease screening (HIV, HBV, HCV, VDRL)
  • Neurological or organ imaging (MRI, CT, Echo)
  • Full medication history to avoid drug interactions
Recognized Transient Risks
  • Mild low-grade fever or headache (post-IV infusion)
  • Minor bruising or soreness at aspiration site
  • Temporary post-dural puncture headache (lumbar route)
  • Absolute contraindications: Active malignancy or pregnancy

6. International Patient Rights & Informed Consent

Every international patient participating in regenerative care at our partner facilities is entitled to fundamental healthcare rights:

  1. Informed Voluntary Consent: You have the right to receive detailed written and verbal explanations in your language regarding procedure rationale, projected benefits, foreseeable risks, and alternative options prior to giving written consent.
  2. Right to Refuse or Withdraw: You maintain the autonomy to refuse or discontinue treatment at any phase without prejudice or penalty.
  3. Dignity & Non-Discrimination: Equal, respectful, and compassionate care regardless of nationality, race, religion, gender, or disability.
  4. Direct Access to Records: Complete transparency regarding cleanroom batch viability certificates, cell counts, laboratory results, and medical discharge summaries.

7. Patient Data Protection & Confidentiality

We take patient confidentiality seriously. All medical inquiries, medical records, diagnostic scans, and personal identifiers submitted through our platform are protected under the Digital Personal Data Protection Act 2023 (DPDP) and align with international GDPR principles:

  • Data is collected strictly to assess clinical eligibility and facilitate medical travel arrangements.
  • We never sell, trade, rent, or distribute personal or health information to third-party commercial advertisers.
  • Medical data is shared solely with treating clinical teams, certified laboratories, and hospital administrators directly involved in your care.

8. Governing Law & Jurisdiction

This disclaimer, our website terms, and any legal disputes or actions arising from the use of this website or communications with our center are exclusively governed by and construed in accordance with the laws of India. Any legal proceedings shall be subject to the exclusive jurisdiction of the competent courts in India.

Check Treatment Eligibility

Confidential case review by our medical board within 24 business hours.